All
AI Mode
Web
Images
Videos
Shorts
Maps
News
More
Shopping
Flights
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
PubMed Central Open Access Subset
Stack
Dataset Python
Open Video Project
Dataset
Didemo
Dataset
Python
Samplefoodsalesdata
Machine Learning in Qsrr
RTO Office Mandate Federal Employees
Bert On Covid
Dataset
Python
Coding Review
Protein Engineering with
Python
Stock API
Cov Caldas
Dataset
Ai for
Material Discovery
Amazon
Python
Python
Data Science Projects
Python for
Data Engineering
How to RIS Export PubMed Collection
CNTE enTc Sppu Practicals
Engraved 2020
Python
Python
Diarrhea
Machine Learning
for Chemistry
PubMed Basics
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
PubMed Central Open Access Subset
Stack
Dataset Python
Open Video Project
Dataset
Didemo
Dataset
Python
Samplefoodsalesdata
Machine Learning in Qsrr
RTO Office Mandate Federal Employees
Bert On Covid
Dataset
Python
Coding Review
Protein Engineering with
Python
Stock API
Cov Caldas
Dataset
Ai for
Material Discovery
Amazon
Python
Python
Data Science Projects
Python for
Data Engineering
How to RIS Export PubMed Collection
CNTE enTc Sppu Practicals
Engraved 2020
Python
Python
Diarrhea
Machine Learning
for Chemistry
PubMed Basics
0:20
FDA orders new warning on GLP-1s over rare eye condition
2K views
1 day ago
YouTube
NBC News
1:27
FDA adds new warning on GLP-1 drugs for rare eye condition
66 views
20 hours ago
YouTube
ABC News
1:32
There’s a new alert on those popular GLP-1 weight loss drugs. The FDA is now mandating a warning label that the drugs may cause sudden blindness. NBC News’ Stephanie Gosk reports.
2.5M views
1 day ago
TikTok
nbcnightlynews
The FDA announced Monday that it is requiring new warnings on popular diabetes and weight loss drugs, including Ozempic, Wegovy, Mounjaro and Zepbound, over a potential increased risk for a rare eye condition that can cause permanent vision loss. https://t.co/QW8TFjeKqT https://t.co/PAmY6nxRou
4.2K views
19 hours ago
x.com
ABC News
2:55
Ozempic Eye Stroke Risk Explained: Warning Signs, Research And What Patients Must Know | N18S
2.2K views
1 day ago
YouTube
CNN-News18
0:20
The FDA is warning that GLP-1 drugs like Ozempic and Zepbound can decrease blood flow to the optic nerve, increasing the risk of vision loss. #weightloss #drugs #fda
3.5M views
1 day ago
TikTok
cbseveningnews
0:16
SDA FDA CURRENT AFFAIRS QUESTIONS #competitiveexams
1K views
1 week ago
YouTube
MNS ACADEMY
0:45
The FDA regulates cigarettes, prescription drugs, and supplements under three completely different sets of rules. Cigarettes can legally be sold despite causing hundreds of thousands of deaths annually. Meanwhile, a promising supplement may never receive FDA approval, regardless of its potential benefits. Here's the distinction most people miss: FDA approval requires evidence of safety and efficacy for a specific use. Supplements generally don't go through that process, and tobacco products are
934 views
4 days ago
TikTok
christianpoulos
1:30
The FDA Doesn't Know What's In Our Food
870 views
4 days ago
YouTube
YourWeeklyCrew
‼️A new FDA data mining report shows they knew the Covid vaccine had 25 major side effects and they all conspired to hide it from the publicSenator Ron Johnson’s Senate PSI Majority Staff Interim Report has been released on FDA data mining and the March 2021 analysis by Dr. Ana https://t.co/ECAnuXvNqf
738 views
21 hours ago
x.com
Paul White Gold Eagle
2:40
Blood Pressure Medication Recall Hits 3,744 Bottles! Olmesartan, Amlodipine: FDA Class II
729 views
1 day ago
YouTube
Dr. Frita
1:57
A new FDA warning does not mean everyone should stop their GLP-1. It means we keep paying attention. The FDA is now requiring a warning about a potential increased risk of NAION, a rare but serious eye condition that can cause sudden, painless vision loss. This is also why GLP-1 treatment should involve a clinician experienced with these medications. Prescribing is only one part of the job. Monitoring side effects, recognizing warning signs, and adjusting treatment appropriately matter too. Sudd
624 views
1 day ago
TikTok
drmakkani
0:32
FDA adds warning to GLP‑1 drug labels, warning of links to rare eye condition
28 views
1 day ago
YouTube
WBIR Channel 10
1:31
Replying to @kevsscalvo fda registered vs fda approved | explained by a medtech #fitness #gym #nutrition #tips #supplements
8.2K views
5 days ago
TikTok
paulaliwalas
1:08
Caitlin’s soap has been banned from sale by the FDA following reports that it caused allergic reactions in customers.#news #caitlin #soap #typ #foryour
3.2M views
6 days ago
TikTok
p0852262
0:59
The US Food and Drug Administration told makers of popular weight-loss GLP-1 drugs that they must add warning labels about a rare eye condition that can cause sudden blindness. #FDA #GLP1 #Weightloss #Blindness #NAION #USNews #BBCNews
424.3K views
18 hours ago
TikTok
bbcnews
1:55
FDA News | दिवाळीत मिठाई खरेदी करताना सावधान! तुकाराम मुंढेंचं नागरिकांना आवाहन
164.7K views
6 days ago
YouTube
News18 Marathi
1:07
Why chocolate tastes bad now
3.9K views
2 days ago
YouTube
Vox
0:54
Jalgaon FDA News | जळगावमध्ये FDAची मोठी कारवाई, लाखोंचा तेलसाठा जप्त
2K views
2 days ago
YouTube
News18 Marathi
0:56
The FDA Didn't Even Know What Was In Our Food
1.2K views
22 hours ago
YouTube
The Sage Steele Show
See more
More like this
Feedback